An interesting article on the dilemma faced by the approving authorities like Nice. Approving drugs that don't work well takes funds away from those that do work well.
push to speed new drug assessments: theconversation.com/faster-...
know about the new drugs Ibrutinib, Idelalisib and obinutuzumab. His latest blog was a 10 question survey...
back with the new drugs. Why not have the clinical trials with only the new drugs and no chemo. I researched...
Start a Community